Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes.

× No keyword cloud information.

9 in total

Review 1. Vildagliptin: a review of its use in type 2 diabetes mellitus.

Authors: Gillian M Keating
Journal: Drugs Date: 2014-04 Impact factor: 9.546

Review 2. Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.

Authors: Bo Ahrén; James E Foley
Journal: Diabetologia Date: 2016-02-19 Impact factor: 10.122

Review 3. DPP4 Activity, Hyperinsulinemia, and Atherosclerosis.

Authors: Kaitlin M Love; Zhenqi Liu
Journal: J Clin Endocrinol Metab Date: 2021-05-13 Impact factor: 5.958

Review 4. The pathophysiology of intestinal lipoprotein production.

Authors: Antonina Giammanco; Angelo B Cefalù; Davide Noto; Maurizio R Averna
Journal: Front Physiol Date: 2015-03-20 Impact factor: 4.566

5. Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.

Authors: Toshiyuki Hayashi; Tomoyasu Fukui; Noriko Nakanishi; Saki Yamamoto; Masako Tomoyasu; Anna Osamura; Makoto Ohara; Takeshi Yamamoto; Yasuki Ito; Tsutomu Hirano
Journal: Cardiovasc Diabetol Date: 2017-01-13 Impact factor: 9.951

6. A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes.

Authors: Seon-Ah Cha; Yong-Moon Park; Jae-Seung Yun; Tae-Seok Lim; Ki-Ho Song; Ki-Dong Yoo; Yu-Bae Ahn; Seung-Hyun Ko
Journal: Lipids Health Dis Date: 2017-04-13 Impact factor: 3.876

7. Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans.

Authors: Changting Xiao; Satya Dash; Cecilia Morgantini; Bruce W Patterson; Gary F Lewis
Journal: Diabetes Date: 2014-02-28 Impact factor: 9.461

8. Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study.

Authors: Niina Matikainen; Sanni Söderlund; Elias Björnson; Kirsi Pietiläinen; Antti Hakkarainen; Nina Lundbom; Marja-Riitta Taskinen; Jan Borén
Journal: Diabetes Obes Metab Date: 2018-09-04 Impact factor: 6.577

Review 9. Effects of Sitagliptin on Lipid Profiles in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Clinical Trials.

Authors: Minhua Fan; Yuelan Li; Shihong Zhang
Journal: Medicine (Baltimore) Date: 2016-01 Impact factor: 1.817

9 in total